Drug Type Small molecule drug |
Synonyms CL 870801 |
Target |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H24ClN5O2 |
InChIKeyAMHDXBBABSDOFM-UHFFFAOYSA-N |
CAS Registry130617-24-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Phase 1 | DE | - | - |
Heart Failure | Phase 1 | - | - | |
Hypertension | Phase 1 | DE | - | - |
Hypertension | Phase 1 | - | - |